Interpreting disparate responses to cancer therapy: the role of human population genetics.

Abstract excerpt

Increasingly, investigators are recognizing differences in tumor biology, drug metabolism, toxicity, and therapeutic response among different patient populations receiving anticancer agents. These observations provide exciting opportunities to identify the factors most important for predicting individual variability in pharmacologically relevant phenotypes and consequently for personalizing the delivery of cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pharmacogenetics
• Share to Antineoplastic Agents